Kexing, Biopharm

Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

Kexing Biopharm China Europe Norway

en | boerse | 67920065 |